MedTrace Logo

Presbyopia-Correcting Intraocular Lenses (IOLs)

NCT00963560 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 132

Last updated 2011-08-09

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to prospectively evaluate postoperative visual and refractive parameters in a series of subjects bilaterally implanted with Presbyopia-Correcting Intraocular Lenses (IOLs).

Conditions

  • Cataract

Interventions

DEVICE

ReSTOR +3

Bilateral implantation of the AcrySof ReSTOR Aspheric +3 Model SN6AD1 Intraocular lens (IOL) for the treatment of cataract.

DEVICE

Crystalens HD

Bilateral implantation of the Crystalens HD intraocular lens (IOL) for the treatment of cataract.

DEVICE

Crystalens AO

Bilateral implantation of the Crystalens AO intraocular lens (IOL) for the treatment of cataract.

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2011-03-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00963560 on ClinicalTrials.gov